Why the study?
Does chenodeoxycholic acid reduce serum triglyceride levels in men with hypertriglyceridaemia not fully controlled by diet?
Does chenodeoxycholic acid reduce serum triglyceride levels in men with hypertriglyceridaemia not fully controlled by diet?
Chenodeoxycholic acid therapy is effective in reducing serum triglycerides in men with hypertriglyceridaemia not fully controlled by diet, with efficacy comparable to clofibrate.
Answers are grounded in this paper and cite their sources.
May support adjunctive use in diet-refractory hypertriglyceridemia; leaves open randomized confirmation.
1 Ten consecutive patients with hypertriglyceridaemia who adhered to a low carbohydrate diet without complete control of serum triglycerides were started on chenodeoxycholic acid 750 mg daily and followed monthly for 6 months. Nine of these patients were then followed for a further month on placebo capsules and thereafter monthly for a further 6 months on clofibrate 2 g daily. 2 The mean serum triglyceride level fell by 36% after dietary treatment alone (P less than 0.05) and by 47% from initial values on diet plus chenodeoxycholic acid (P less than 0.01). In the nine patients who proceeded to clofibrate therapy there was a rise in triglyceride levels on placebo capsules to the level achieved by diet alone, and a further fall on diet plus clofibrate of 47% of initial values (P less than 0.05). 3 Chenodeoxycholic acid therapy is effective in the management of hypertriglyceridaemia not completely cured by dietary measures, and may be as efficacious as clofibrate.
No takes yet. Share an insight, caveat, or question.
Bateson et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: